Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/60047
Type
ArticleCopyright
Restricted access
Embargo date
3100-12-31
Collections
Metadata
Show full item record
NEUROTOXIC EFFECTS OF HALLUCINOGENIC DRUGS 25H-NBOME AND 25H-NBOH IN ORGANOTYPIC HIPPOCAMPAL CULTURES.
25H-NBOH
Phenethylamines
Organotypic hippocampal culture
Neurotoxicity
Neurogenesis
Author
Affilliation
Fundação Oswaldo Cruz. Instituto René Rachou Neurogenômica, Imunopatologia. Belo Horizonte, MG, Brazil/Universidade Federal de Minas Gerais. Programa de Pós-Graduação em Bioquímica e Imunologia. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Instituto René Rachou Neurogenômica, Imunopatologia. Belo Horizonte, MG, Brazil
Universidade Federal de Minas Gerais. Programa de Pós-Graduação em Bioquímica e Imunologia. Belo Horizonte, MG, Brazil
Universidade Federal de Minas Gerais. Programa de Pós-Graduação em Bioquímica e Imunologia. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Instituto René Rachou. Neurogenômica, Imunopatologia. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Instituto René Rachou Neurogenômica, Imunopatologia. Belo Horizonte, MG, Brazil
Universidade Federal de Minas Gerais. Programa de Pós-Graduação em Bioquímica e Imunologia. Belo Horizonte, MG, Brazil
Universidade Federal de Minas Gerais. Programa de Pós-Graduação em Bioquímica e Imunologia. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Instituto René Rachou. Neurogenômica, Imunopatologia. Belo Horizonte, MG, Brazil
Abstract
Introduction: NBOMes and NBOHs are psychoactive drugs derived from phenethylamines and have hallucinogenic effects due to their strong agonism to serotonin 5-HT2A receptors. Although cases of toxicity associated with the recreational use of substituted phenethylamines are frequently reported, there is a lack of information on the possible neurotoxic effects of NBOMe and NBOH in the brain hippocampus, a major neurogenesis region.
Objectives: This study aimed at assessing the phenotypic and molecular effects of prolonged exposure of the hippocampus to the drugs 25H-NBOMe and 25H-NBOH.
Methods: The ex vivo organotypic culture model of hippocampal slices (OHC) was used to investigate, by immunofluorescence and confocal microscopy, and transcriptome analyses, the mechanisms associated with the neurotoxicity of 25H-NBOMe and 25H-NBOH.
Results: Reduction in the density of mature neurons in the OHCs occurred after two and seven days of exposure to 25H-NBOMe and 25H-NBOH, respectively. After the withdrawal of 25H-NBOMe, the density of mature neurons in the OHCs stabilized. In contrast, up to seven days after 25H-NBOH removal from the culture medium, progressive neuron loss was still observed in the OHCs. Interestingly, the exposure to 25H-NBOH induced progenitor cell differentiation, increasing the density of post-mitotic neurons in the OHCs. Corroborating these findings, the functional enrichment analysis of differentially expressed genes in the OHCs exposed to 25H-NBOH revealed the activation of WNT/Beta-catenin pathway components associated with neurogenesis. During and after the exposure to 25H-NBOMe or 25H-NBOH, gene expression patterns related to the activation of synaptic transmission and excitability of neurons were identified. Furthermore, activation of signaling pathways and biological processes related to addiction and oxidative stress and inhibition of the inflammatory response were observed after the period of drug exposure.
Conclusion: 25H-NBOMe and 25H-NBOH disrupt the balance between neurogenesis and neuronal death in the hippocampus and, although chemically similar, have distinct neurotoxicity mechanisms.
Keywords
25H-NBOMe25H-NBOH
Phenethylamines
Organotypic hippocampal culture
Neurotoxicity
Neurogenesis
Share